Home Oxygen Treatment of Childhood Acute Bronchiolitis
NCT01618175 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85
Last updated 2012-06-13
Summary
Background: acute bronchiolitis (AB) is a common reason for hospitalization of infants in all population groups, and is usually due to respiratory syncytial virus (RSV) infection. The main cause for hospitalization is often a need for oxygen, but can also include high fever (with a suspected secondary bacterial infection) or increasing respiratory distress. In a minority of cases (some of which can be identified in advance by defining risk groups) a serious illness may develop, including risk of respiratory failure and death. Most cases will just require supplemental oxygen and suction of secretions from the nose (as listed in the recommendations of the American Academy of Pediatrics - AAP). However, this apparently "simple" treatment still requires continued hospitalization. This results in a sharp increase in bed occupancy in Israeli hospital pediatric departments in the winter months. In recent years two studies from developed countries have been published where safety has been demonstrated for home oxygen treatment for babies with AB. However, feasibility studies have not been published yet, for example for populations living in poor conditions. The General Health Services (Klalit) in Israel provides integrated hospital and community health service to the majority of the population living o in our region, thus presenting an opportunity for optimal interventions related to this disease.
Conditions
- Bronchiolitis, Viral
- Home Nursing
Interventions
- DEVICE
-
Home oxygen therapy
Oxygen will be provided using a generator, through nasal prongs at a flow rate up to 1 L/min. During home stay the parents will be guided on how to suspect signs of clinical deterioration. General treatment: If oxygen saturation by pulse oximeter is greater than 92%, the oxygen will be reduced by a quarter liter per minute while monitoring for 15 minutes. If oxygen saturation decreased to less than 92% of the child will remain with the best previous oxygen flow until the next visit. Once the child reaches - 0.06 l / min for 15 minutes, he will will be checked back on room air. Cessation of oxygen therapy: when the oxygen saturation remains above 92% on room air. Every day that no home visit was performed a phone call will be done and follow-up questionnaire will be filled daily, including oxygen saturation registration.
Sponsors & Collaborators
-
Soroka University Medical Center
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 2 Months
- Max Age
- 24 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2013-06-30
- Completion
- 2014-08-31
More Related Trials
-
High-flow Nasal Oxygen Therapy in Hospitalized Infant With Moderate-to-severe Bronchiolitis
NCT02856165 ·Status: COMPLETED ·Phase: NA
-
Hypertonic Saline Inhalation in Acute Bronchiolitis
NCT03880903 ·Status: UNKNOWN ·Phase: PHASE4
-
Hypertonic Saline for Acute Bronchiolitis
NCT01247064 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of 3% Hypertonic Saline Inhalation (24h vs 72h) to Treat Acute Bronchiolitis in Hospitalized Infants
NCT02538458 ·Status: COMPLETED ·Phase: PHASE4
-
Study of High-flow Oxygen Therapy Against Standard Therapy in Bronchiolitis
NCT01498094 ·Status: COMPLETED ·Phase: NA
-
Nasal Irrigation in Infants With Bronchiolitis.
NCT02162745 ·Status: COMPLETED ·Phase: PHASE3
-
High Flow Oxygen Therapy vs Standard Care in Infants With Viral Bronchiolitis
NCT03252119 ·Status: TERMINATED ·Phase: NA
-
Hypertonic Saline to Reduce Hospital Admissions in Bronchiolitis
NCT00677729 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Nebulised Hypertonic Saline (3%) Among Children With Bronchiolitis.
NCT01276821 ·Status: COMPLETED ·Phase: PHASE4
-
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
NCT01014910 ·Status: COMPLETED ·Phase: NA
-
HYPERTONIC SALINE IN ACUTE VIRAL BRONCHIOLITIS: A RANDOMIZED CLINICAL TRIAL
NCT00729274 ·Status: WITHDRAWN ·Phase: NA
-
7% Hypertonic Saline for Acute Bronchiolitis
NCT01871857 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Nebulized Hypertonic Saline and Epinephrine in Hospitalized Infants With Bronchiolitis
NCT01300325 ·Status: COMPLETED ·Phase: PHASE4
-
Safety of Airway Clearance in Non-hospitalized Infants With Acute Viral Bronchiolitis
NCT03835858 ·Status: COMPLETED ·Phase: NA
-
Oxygen Saturation Monitoring in Bronchiolitis
NCT02947204 ·Status: COMPLETED ·Phase: NA
-
Heated High Flow Oxygen Use in Infants With Bronchiolitis and Hypoxia
NCT01662544 ·Status: UNKNOWN ·Phase: NA
-
Nebulised 3% Hypertonic Saline Versus 0.9% Saline for Treating Patients Hospitalized With Acute Bronchiolitis
NCT06069336 ·Status: COMPLETED ·Phase: NA
-
Cough Assist in Bronchiolitis
NCT01757496 ·Status: TERMINATED ·Phase: NA
-
Nebulized 3% Hypertonic Saline Solution Treatment of Bronchiolitis in Infants
NCT02233985 ·Status: COMPLETED ·Phase: PHASE4
-
Prone Position in Acute Bronchiolitis
NCT03976895 ·Status: COMPLETED ·Phase: NA
-
Efficacy of 3% Hypertonic Saline in Acute Viral Bronchiolitis
NCT01777347 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of 3% Hypertonic Saline and Salbutamol in Children With Bronchiolitis
NCT06665711 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Peak Tidal Inspiratory Flow in Infants With Moderate to Severe Acute Viral Bronchiolitis
NCT03298217 ·Status: COMPLETED ·Phase: NA
-
Treatment Of Bronchiolitis With Heated Humidified High Flow Nasal Cannula - Prospective And Retrospective Research
NCT02366715 ·Status: UNKNOWN ·Phase: PHASE3
-
The Use of an Inhaled Salt Solution to Treat Viral Lung Infections in Infants.
NCT00151905 ·Status: COMPLETED ·Phase: PHASE2/PHASE3